DK0655244T5 - Sammensætning på basis af aminosyrer til behandling af infektioner - Google Patents
Sammensætning på basis af aminosyrer til behandling af infektionerInfo
- Publication number
- DK0655244T5 DK0655244T5 DK94402420T DK94402420T DK0655244T5 DK 0655244 T5 DK0655244 T5 DK 0655244T5 DK 94402420 T DK94402420 T DK 94402420T DK 94402420 T DK94402420 T DK 94402420T DK 0655244 T5 DK0655244 T5 DK 0655244T5
- Authority
- DK
- Denmark
- Prior art keywords
- cysteine
- amino acids
- proportion
- composition based
- treat infections
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 150000001413 amino acids Chemical class 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title 1
- 235000018417 cysteine Nutrition 0.000 abstract 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 4
- 235000001014 amino acid Nutrition 0.000 abstract 2
- 108010009736 Protein Hydrolysates Proteins 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9312884A FR2711529B1 (fr) | 1993-10-28 | 1993-10-28 | Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme. |
Publications (2)
Publication Number | Publication Date |
---|---|
DK0655244T3 DK0655244T3 (da) | 2002-08-05 |
DK0655244T5 true DK0655244T5 (da) | 2008-10-13 |
Family
ID=9452315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94402420T DK0655244T5 (da) | 1993-10-28 | 1994-10-27 | Sammensætning på basis af aminosyrer til behandling af infektioner |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0655244B2 (de) |
KR (1) | KR950010884A (de) |
AT (1) | ATE216234T1 (de) |
CA (1) | CA2134380C (de) |
DE (1) | DE69430416T3 (de) |
DK (1) | DK0655244T5 (de) |
ES (1) | ES2171439T5 (de) |
FR (1) | FR2711529B1 (de) |
PT (1) | PT655244E (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999038507A1 (en) * | 1998-01-30 | 1999-08-05 | David George Le Couteur | Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation |
BRPI0108096B1 (pt) * | 2000-02-04 | 2017-05-09 | Nestle Sa | usos de uma fonte de proteína compreendendo aminoácidos em que o teor de treonina é de pelo menos 5,5% em peso dos aminoácidos |
EP1302115A1 (de) * | 2001-10-16 | 2003-04-16 | Societe Des Produits Nestle S.A. | Verwendung von Cystathionin |
WO2005077400A1 (en) * | 2004-02-12 | 2005-08-25 | Campina Nederland Holding B.V. | Cysteine rich peptides for improving thiol homeostasis |
EP1890688A2 (de) * | 2005-06-14 | 2008-02-27 | Nestec S.A. | Ernährungsmethode |
DE102006018293A1 (de) * | 2006-04-20 | 2007-10-25 | Fresenius Kabi Deutschland Gmbh | Pädiatrische Aminosäurelösung zur parenteralen Ernäherung |
EP2165713B1 (de) | 2008-09-19 | 2012-11-14 | Nestec S.A. | Molke und Verbesserung der Thymusfunktion |
WO2011021926A1 (en) * | 2009-08-21 | 2011-02-24 | N.V. Nutricia | Regulating the amino acid pool used for the acute-phase protein synthesis |
EP2444083A1 (de) | 2010-10-21 | 2012-04-25 | Nestec S.A. | Cystein- und Nahrungsmittelaufnahme |
WO2024122796A1 (ko) * | 2022-12-05 | 2024-06-13 | 의료법인 성광의료재단 | 아스파르트산을 유효성분으로 포함하는 패혈증의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2531204C2 (de) * | 1975-07-12 | 1987-01-22 | Fresenius AG, 6380 Bad Homburg | L-Aminosäuregemische für die parenterale oder orale Ernährung |
DE2946563C2 (de) * | 1979-11-17 | 1987-04-30 | B. Braun Melsungen Ag, 3508 Melsungen | Aminosäurelösung zur parenteralen Infusion |
DE3026368A1 (de) * | 1980-07-11 | 1982-02-18 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion |
US4604286A (en) * | 1984-09-17 | 1986-08-05 | Daigo Nutritive Chemicals, Ltd. | Infusion solution for parenteral nutrition |
AU605214B2 (en) * | 1986-10-24 | 1991-01-10 | Fresenius Kabi Ab | N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration |
SE8704217D0 (sv) * | 1987-10-29 | 1987-10-29 | Vinnars Erik Ab | Aminosyrakomposition for parenteral neringstillforsel |
US5224409A (en) † | 1991-03-19 | 1993-07-06 | Ashlock Company | Apparatus for producing helical slices |
US5214062A (en) † | 1992-04-08 | 1993-05-25 | Clintec Nutrition Co. | Method and composition for treating immune disorders, inflammation and chronic infections |
AU6060694A (en) † | 1993-05-10 | 1994-11-17 | Transcend Therapeutics, Inc | Method for treating acquired immune deficiency syndrome |
-
1993
- 1993-10-28 FR FR9312884A patent/FR2711529B1/fr not_active Expired - Lifetime
-
1994
- 1994-10-26 CA CA2134380A patent/CA2134380C/en not_active Expired - Lifetime
- 1994-10-27 DK DK94402420T patent/DK0655244T5/da active
- 1994-10-27 ES ES94402420T patent/ES2171439T5/es not_active Expired - Lifetime
- 1994-10-27 PT PT94402420T patent/PT655244E/pt unknown
- 1994-10-27 EP EP94402420A patent/EP0655244B2/de not_active Expired - Lifetime
- 1994-10-27 DE DE69430416T patent/DE69430416T3/de not_active Expired - Lifetime
- 1994-10-27 AT AT94402420T patent/ATE216234T1/de not_active IP Right Cessation
- 1994-10-28 KR KR1019940027823A patent/KR950010884A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE69430416T3 (de) | 2009-01-22 |
DE69430416D1 (de) | 2002-05-23 |
EP0655244A1 (de) | 1995-05-31 |
KR950010884A (ko) | 1995-05-15 |
ES2171439T3 (es) | 2002-09-16 |
DK0655244T3 (da) | 2002-08-05 |
FR2711529A1 (fr) | 1995-05-05 |
EP0655244B1 (de) | 2002-04-17 |
CA2134380A1 (en) | 1995-04-29 |
FR2711529B1 (fr) | 1996-07-05 |
DE69430416T2 (de) | 2002-12-05 |
CA2134380C (en) | 2010-06-22 |
PT655244E (pt) | 2002-08-30 |
ES2171439T5 (es) | 2008-12-01 |
EP0655244B2 (de) | 2008-06-11 |
ATE216234T1 (de) | 2002-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2016950T3 (da) | Farmaceutisk sammensætning omfattende et exendin-4-peptid | |
ATE402957T1 (de) | Analoge des menschlichen interferon-alpha mit niedriger toxizität | |
GEP20074123B (en) | Amino acids with affinity for the alpha−2−delta−protein | |
PE20000560A1 (es) | Uso de peg-ifn-alfa y ribavirina para el tratamiento de hepatitis c cronica | |
ES2141229T3 (es) | Productos farmaceuticos de proteinas y peptidos modificados. | |
RS20090086A (en) | Nucleoside analogs with carobxamidine modified monocyclic base | |
DE59810596D1 (de) | Humanes, rekombinantes interferon-beta mit verbesserter löslichkeit | |
DK0655244T5 (da) | Sammensætning på basis af aminosyrer til behandling af infektioner | |
AR015498A1 (es) | Composiciones de edulcorante de mesa. | |
GEP20063763B (en) | Thrombopoietin Receptor Modulating Peptide | |
ATE62407T1 (de) | Geschmack abdeckende zusammensetzungen. | |
ATE69164T1 (de) | Arzneimittel zur behandlung von uraemie. | |
MY124560A (en) | Amino acid compositions and use thereof in immunosuppression | |
ES2087337T3 (es) | Composiciones de implantes que contienen una proteina, peptido o polipeptido biologicamente activos. | |
DE60001489D1 (de) | Pharmazeutische zubereitung für die intravenöse oder intramuskuläre verabreichung von octreotid | |
UY24780A1 (es) | Composiciones farmacéuticas estabilizadas a base de quinupristina y dalfopristina y su preparación. | |
ATE93527T1 (de) | Peptide und deren benutzung. | |
FI942938A (fi) | Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan | |
EP1557466A4 (de) | Tumorantigenprotein und dessen verwendung | |
WO1998001474A3 (en) | Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth | |
FR2710244B3 (fr) | Composition diététique à base d'acides aminés essentiels. | |
IT1247493B (it) | Sali ad attivita' antiinfiammatoria, analgesica e antipiretica e composizioni farmaceutiche che li contengono | |
ITMI931822A1 (it) | Composizioni farmaceutiche a base di nimesulide, somministrabili per via orale, non gastrolesive e/o a rilascio controllato | |
SE8700125D0 (sv) | Korta peptider vid behandling av psoriasis och schizofreni |